Scores of 20–25 are classified as well-controlled asthma; 16–19 as not
well-controlled; and 5-15 as very poorly controlled asthma. N ,
total number of qualified subjects for evaluation; n (%),
frequency (percentage of frequency); 95% CI, 95% confidence interval.
Of note, during the COVID-19 epidemic, 13.5% (24/178) of the patients
had worried about insufficient maintenance medications, among whom
45.8% (11/24) had reduced medication dosing for this reason. After
reducing medication dosing, 27.3% (3/11) of them experienced asthma
aggravation. Among patients who had their prescriptions refilled during
the COVID-19 epidemic, 60.6% (40/66) chose to go to a hospital, 36.4%
(24/66) chose a nearby pharmacy, and 3.0% (2/66) chose to purchase
online.
For patients on maintenance therapy (n=105), 93.3% (98/105) used two or
even three drugs, as illustrated in Table 2. ICS plus LABA was the most
commonly used therapy, followed by ICS/LABA plus oral leukotriene
modifiers.
Table 2 Current maintenance therapy during the COVID-19 pandemic